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Correspondence m.luijsterburg@lumc.nl (M.S.L.), h. van.attikum@lumc.nl (H.v.A.) In Brief Luijsterburg et al. define a PARP1dependent mechanism that regulates NHEJ through localized chromatin expansion and deposition of the histone variant H3.3 by the nucleosome remodeler CHD2 at DNA breaks. Their data also show that these CHD2mediated events promote DNA repair by facilitating the assembly of NHEJ complexes in chromatin.
INTRODUCTION
DNA double-strand breaks (DSBs) are a considerable threat to the integrity of the human genome and, if not properly dealt with, can cause genomic instability and cancer. The response to DSBs entails a coordinated series of events known as the DNA damage response (DDR), which integrates the regulation of cell cycle progression with DSB repair mechanisms through DNA damage signaling pathways (Polo and Jackson, 2011) .
In eukaryotes, DSBs are primarily repaired by two pathways: homologous recombination (HR) and non-homologous endjoining (NHEJ). HR operates in the S and G2 stages of the cell cy-cle and requires extensive resection of DSBs to generate stretches of single-stranded DNA, which are acted upon by the single-stranded DNA-binding protein RPA and the recombinase RAD51. These and other factors subsequently facilitate the error-free repair of DSBs by using the sister chromatid as a template (Symington and Gautier, 2011) . In contrast, NHEJ, which is the dominant DSB repair pathway in mammalian cells, requires minimal DNA-end processing. Initiation of NHEJ involves the binding of the KU70-KU80 complex to broken DNA ends followed by the assembly of the DNA-dependent protein kinase (DNA-PK) and the XRCC4-LigIV complex (Lieber, 2010) .
DSB repair takes place on genomic DNA that is packaged together with histone proteins into an often-inaccessible structure called chromatin. Regulating the accessibility of damaged DNA requires a high degree of coordination between DSB repair machineries and chromatin-modifying enzymes (Luijsterburg and van Attikum, 2011; .
Initial studies using photo-activatable GFP fused to the core histone H2B revealed that DNA damage triggers the localized expansion of chromatin in an ATP-dependent fashion (Kruhlak et al., 2006) . Subsequent studies uncovered that this localized chromatin expansion requires the activity of poly(ADP-ribose) polymerase (PARP) enzymes and promotes DNA damage signaling by the RNF168 ubiquitin ligase . The initial rapid expansion of chromatin is followed by the localized compaction of chromatin (Burgess et al., 2014; Khurana et al., 2014) , suggesting that specific chromatin configurations regulate different aspects of the DDR. In particular, localized chromatin compaction, which is regulated by the PRDM2 histone methyltransferase, regulates DNA-end resection and promotes DSB repair by HR (Khurana et al., 2014) . In addition to chromatin compaction, a number of ATP-dependent chromatin remodelers (e.g., SMARCAD1, INO80, p400, and CHD4) that are usually associated with chromatin decondensation have also been linked to regulating end resection or other steps during HR . These findings suggest that HR is tightly regulated by dynamic changes in chromatin structure.
Despite these considerable insights into dynamic changes in chromatin structure during DNA damage signaling and HR, we know very little about alterations in chromatin structure that may play a role in NHEJ. To fill this gap, we sought to characterize chromatin changes that play a role in NHEJ in human cells and identify a previously uncharacterized pathway involved in this process.
RESULTS

PARP1 Promotes Chromatin Expansion and Spreading of NHEJ Factor XRCC4
We sought to characterize changes in chromatin structure in response to DNA damage that may play a role in NHEJ. To this end, we revisited a method to locally inflict DNA damage and simultaneously activate histone H2A fused to a photo-activatable version of GFP (PA-GFP) using multiphoton micro-irradiation ( Figure 1A ) (Kruhlak et al., 2006; . Local irradiation triggered the rapid expansion of PAGFP-H2A tracks in control cells, but not in cells treated with the PARP inhibitor (Figures 1B and 1C) , suggesting that DNA damage-induced chromatin changes depend on the activity of PARP enzymes. To monitor possible chromatin changes involved in NHEJ, we generated U2OS cells stably expressing a GFP-tagged version of the core NHEJ protein XRCC4. Local irradiation triggered the accumulation of GFP-XRCC4 in laser tracks, which displayed considerable expansion over time (Figures 1D and 1E) . Strikingly, treatment of cells with PARP inhibitor or knockdown of PARP1 significantly reduced the expansion of GFP-XRCC4 tracks, suggesting that PARP1-dependent changes in chromatin structure may play a role in NHEJ ( Figures 1D and 1E ; Figures S1A and S1B).
The Chromatin Remodeler CHD2 Is an Interactor of PARP1 We then set out to identify factors that regulate these chromatin changes by analyzing PARP1-associated chromatin-modifying proteins using a previously described chromatin-tethering approach . To this end, we fused PARP1 to the lactose repressor protein (LacR) and expressed the fusion protein in U2OS cells harboring stably integrated LacO repeats. These cells were subsequently transfected with a representative collection of GFP-tagged SWI2/SNF2 ATPases from the four major chromatin remodeling families (SWI/SNF, ISWI, INO80, and CHD). This approach identified the chromodomain helicase DNA-binding protein 2 (CHD2) as a possible inter-actor of PARP1 ( Figure 1F ; Figure S1C ). Co-immunoprecipitation (coIP) confirmed the interaction between endogenous PARP1 and CHD2, which was completely abolished by treatment with PARP inhibitor ( Figure 1G ). This suggests that the association between CHD2 and PARP1 is not mediated by protein-protein interactions but may involve the association of CHD2 with poly(ADP-ribose) (PAR) chains on PARP1 ( Figure 1G ).
To further study the interaction between CHD2 and PARP1, we stably expressed GFP-tagged CHD2 in U2OS cells at levels roughly similar to endogenous CHD2 ( Figure 1H ). Immunoprecipitation of CHD2-GFP followed by mass spectrometry (MS) after SILAC revealed 139 proteins that were at least 2-fold enriched compared with control cells (Table S1 ). This analysis not only revealed interactions with all core histones and the related chromatin remodeler CHD1, but it also confirmed PARP1 as a robust CHD2-interacting protein ( Figure 1I ). CoIP analysis of CHD2-GFP revealed endogenous PARP1 in the IP fraction, further establishing this interaction ( Figure 1J ). To test if CHD2 is a substrate of PARP1, we immunoprecipitated GFP or CHD2-GFP from cells under denaturing conditions and analyzed their PARylation status by western blotting. This revealed that CHD2 is indeed a substrate of poly(ADP-ribosyl)ation ( Figure 1K ). We conclude that CHD2 is an interactor of PARP1 and decided to study its role in DSB repair.
CHD2 Accumulates at Sites of DNA Damage
To determine if CHD2 acts locally at sites of DNA damage, we tested its recruitment to laser-inflicted DNA DSBs. Endogenous CHD2 was rapidly recruited to DNA damage tracks marked by gH2AX following UV-A micro-irradiation ( Figure 1L ) or multiphoton laser irradiation ( Figure 2C ). Control experiments showed that siRNA-mediated knockdown of CHD2 abolished CHD2 signals in laser tracks, demonstrating the specificity of the CHD2 antibody ( Figure 1L ). Moreover, GFP-tagged CHD2 also rapidly localized to sites of laser-induced DNA damage in both G1 and S/G2 cells ( Figure 1M ; Figures S1D and S1E). These findings show that CHD2 is recruited to sites of DNA damage.
PARP1 Recruits CHD2 to Sites of DNA Damage
To assess a potential role of PARP1's catalytic activity in CHD2 recruitment to sites of DNA damage, we measured the association kinetics of CHD2 using live-cell imaging. A time-course analysis revealed that the rapid (t 1/2 = 5 s) accumulation of CHD2 reached a maximum around 1 min after which the steady-state bound levels gradually decreased within 5 min (Figures 2A and B) . Treatment of cells with PARP inhibitor, which prevented PAR chain formation in laser tracks ( Figure S1F ), completely abolished the recruitment of CHD2-GFP (Figures 2A and 2B) , as well as that of endogenous CHD2 into gH2AX-positive laser tracks ( Figure 2C ). This effect was phenocopied by siRNA-mediated depletion of PARP1, but not PARP2 ( Figures 2D-2F ), suggesting that CHD2 recruitment is strictly dependent on PARP1. Although PARP1 is responsible for 85% of the synthesized PAR chains in response to DNA damage, such chains are rapidly hydrolyzed by the activity of poly(ADP-ribose) glycohydrolase 1 (PARG), which explains the rapid turnover of PAR chains at sites of DNA damage (Pines et al., 2013) . To prevent this rapid turnover, we increased the steady-state levels of chromatin-associated PAR chains by depletion of PARG . Live-cell imaging showed that PARG knockdown dramatically increased the retention time of CHD2 on damaged chromatin (Figures 2D and 2F) . To extend these findings, we overexpressed mCherry-tagged PARG WT or catalytically dead PARG E756D , which completely suppressed CHD2-GFP recruitment (Figures S1G and S1H). Of note, catalytically dead PARG accumulated more strongly likely due to its inability to hydrolyze PAR chains, suggesting that this mutant protein may suppress CHD2 recruitment by direct competition for PAR binding. In conclusion, CHD2 recruitment to DSB-containing chromatin requires the PARP1-mediated synthesis of PAR chains.
A Conserved Region in CHD2 Mediates DNA Damage Accumulation and PAR Binding
To gain more insight into how CHD2 is recruited in a PAR-dependent manner, we generated a series of deletion mutants spanning the whole CHD2 protein ( Figure 3A ). Immunoblotting confirmed that the GFP-tagged deletion mutants were expressed at the correct molecular weight ( Figure 3B ). We then co-expressed these mutant proteins with NBS1-mCherry in cells depleted for endogenous CHD2 and subsequently assessed their ability to accumulate at DSBs. Regions of CHD2 spanning its chromodomains (CHD2 1-461 ), ATPase/helicase domains (CHD2 462-951 ) or putative SANT-SLIDE motif (CHD2 952-1391 ; Figure S2A) failed to accumulate in cells that did accumulate NBS1-mCherry ( Figures 3C and 3D ). Conversely, CHD2 1392-1828 robustly accumulated in laser tracks ( Figures 3C and 3D ). An in silico analysis of the minimal recruitment region identified a putative PAR-binding motif that almost matches the consensus ( Figure S2B ) (Gagné et al., 2008) . Surprisingly, however, a region encompassing this putative PAR-binding region (CHD2 1392-1610 ) failed to accumulate (Figures 3C and 3D) even when fused to an NLS ( Figure S2C ), whereas the last C-terminal 200 amino acids (CHD2 1611-1828 ) were sufficient to mediate PAR-dependent accrual at DSBs ( Figures 3C and 3D ). Indeed, full-length CHD2 lacking this region (CHD2 1-1610 ) failed to accumulate at DSBs ( Figures 3C and 3D ), suggesting that the region spanning residues 1611-1828 regulates the PAR-dependent recruitment of CHD2. To further corroborate these findings, we carried out in vitro PAR-binding studies by incubating immunoprecipitated GFP-tagged wild-type and mutant CHD2 protein with 32 P-radiolabeled PAR chains using southwestern blotting. This revealed that both CHD2 WT and CHD2 1611-1828 indeed bind PAR chains with equal efficiency (Figures 3E and 3F) . Although it did not support recruitment to laser tracks ( Figures 3C and 3D ), we could also detect PAR binding of CHD2 1392-1610 , albeit almost 3-fold weaker compared to the minimal recruitment region (CHD2 1611-1828 ) ( Figures 3E and 3F ). Southwestern analysis with recombinant proteins confirmed the 3-fold stronger association of CHD2 1611-1828 with PAR chains in vitro compared to CHD2 1392-1610 ( Figure S2D ). Notably, the CHD2 1392-1610 fragment failed to support PAR binding in the context of the larger CHD2 protein because we did not detect appreciable PAR binding for the CHD2 1-1610 mutant containing this region (Figures 3E and 3F) . Of note, coIPs showed that CHD2 1611-1828 interacted only weakly with PARP1, whereas CHD2 WT and CHD2 1-1610 robustly pulled down PARP1 ( Figure 3E ), suggesting that the PAR-binding region is distinct from the PARP1-interacting region. Indeed, we found that fragment CHD2 , which failed to support recruitment to sites of DNA damage, was sufficient to bind PARP1 ( Figure 3E ). In conclusion, we have mapped the PAR-binding region in CHD2 and show that this region is sufficient and required for CHD2 recruitment to DSBs.
CHD2 Protects Human Cells against IR
To test whether the recruitment of CHD2 bears any functional significance for DSB repair, we addressed whether this chromatin remodeler protects human cells against the deleterious consequences of ionizing radiation (IR)-induced DSBs. Depletion of CHD2 from SV40-immortalized VH10 human fibroblasts using three independent siRNAs reduced the clonogenic survival of these cells after IR to the same extent as knockdown of DSB repair factor XRCC4 ( Figure 4A ; Figure S3A ). To corroborate these findings, we stably expressed three different shRNAs targeting CHD2 and one shRNA against the key DDR kinase ATM in hTERT-immortalized VH10 human fibroblasts. This approach confirmed that loss of CHD2 renders human cells highly sensitive to IR ( Figure S3B ) and raises the question how CHD2 is involved in DSB repair. CHD2 Promotes DSB Repair by NHEJ Chromosomal DSBs are repaired by HR or NHEJ. To test if CHD2 may be involved in these DSB repair pathways, we utilized GFPbased assays that rely on the repair of DSBs in the GFP gene generated by the I-SceI endonuclease. Flow cytometric analysis of DR-GFP reporter cells for HR ( Figure S3C ) showed a dramatic increase in GFP-positive cells following I-SceI expression, which was severely suppressed by siRNA-mediated depletion of the core HR factor BRCA2 ( Figure S3D ). However, three independent siRNAs against CHD2 did not substantially impair repair by HR and neither did depletion of the core NHEJ factor XRCC4 ( Figures  S3D and S3E ). In addition, RAD51 foci formation after IR in S-phase cells was also not affected by depletion of CHD2, confirming that CHD2 does not promote HR ( Figures S3F and S3G) .
Conversely, analysis of EJ5-GFP reporter cells for NHEJ ( Figure 4B ) revealed a reproducible decrease in NHEJ efficiency upon depletion of CHD2 by six independent siRNAs, which was comparable to the defect observed after depletion of XRCC4 ( Figure 4C ; Figure S4A ). As expected, depletion of the HR factor BRCA2 did not affect NHEJ ( Figure 4C ). The (C) Recruitment of CHD2-GFP deletion mutants in cells depleted for endogenous CHD2 by siCHD2-69 or siCHD2-17 in case of CHD2 952-1391 -GFP. CHD2 1-1611 -GFP was rendered siCHD2-69-resistant. NBS1-mCherry was a DNA damage marker. (D) Quantification of (C). 10-30 cells were analyzed from two independent experiments. (E) IP of the indicated CHD2-GFP fragments from HEK293 cells followed by southwestern blotting to monitor association with radiolabeled PAR. Recombinant PARP1 was a control. CoIP with endogenous PARP1 is shown in the bottom panel.
(F) Quantification of (E) and two additional independent experiments. PAR binding levels of CHD2 WT -GFP were set to 1.
EJ5-GFP reporter provides a readout for total NHEJ activity, but it is not specific for canonical NHEJ (cNHEJ) or alternative NHEJ (aNHEJ), which comprise the two major pathways of NHEJ . To address if PARP1 and CHD2 play a role in cNHEJ, we used random plasmid integration into genomic DNA as a measure for cNHEJ ( Figure 4D ) (Galanty et al., 2009) . Knockdown of the core NHEJ factors KU80 or DNA-PKcs nearly abrogated plasmid integration, confirming that this process largely depends on cNHEJ ( Figure 4E ; Figure S4B ). Significantly reduced cNHEJ activity was also observed following depletion of either CHD2 or PARP1 with two independent siRNAs per gene ( Figure 4E ; Figure S4B ), suggesting that both of these factors contribute to DSB repair by cNHEJ. Importantly, knockdown of CHD2 did not affect the steady-state levels of NHEJ proteins or PARP1 arguing against indirect effects due to transcriptional misregulation ( Figure S4C ).
As an alternative means to study NHEJ, we exploited the notion that loss of the shelterin complex at telomeres causes NHEJdependent chromosome-end fusions (Smogorzewska et al., 2002) . To study the role of CHD2 in this process, we used mouse embryonic fibroblasts containing a temperature-sensitive allele of the shelterin protein TRF2 (TRF2 ts ) . At the non-permissive temperature of 39 C, TRF2 ts -mediated telomere protection is lost, subsequently triggering the NHEJdependent fusion of uncapped chromosome ends ( Figure 4F ). Strikingly, knockdown of CHD2 by three individual shRNAs significantly lowered the number of fused chromosomes in comparison to a control shRNA in TRF2 ts cells grown at non-permissive temperatures (Figures 4G-4I; Figure S4D ). A comparable decrease in chromosome-end fusions was observed in cells depleted for the core NHEJ factor LigIV ( Figures 4G-4I ). In line with previous findings (Sfeir and de Lange, 2012) , we found that knockdown of PARP1, in contrast to CHD2 knockdown, did not reduce the formation of NHEJ-mediated chromosome fusions (Figures S4E and S4F) , suggesting that at uncapped telomeres, CHD2 may act through a PARP1-independent mechanism. These findings suggest that CHD2 contributes to cNHEJ activity in mouse cells and, as such, promotes chromosome-end fusions at uncapped telomeres. Thus, although dispensable for repair by HR, our findings implicate CHD2 in DSB repair by NHEJ. We next set out to determine how CHD2 affects this DSB repair pathway.
CHD2 Promotes the Recruitment of Core NHEJ Factors
The repair of chromosomal DSBs by NHEJ depends on the binding of the KU70-KU80 dimer to broken DNA ends followed by the recruitment of the DNA-PKcs kinase . The XRCC4-LigIV complex is subsequently recruited to DSBs to seal the break. To monitor interactions between CHD2 and NHEJ proteins, we performed reciprocal coIP experiments, which revealed an interaction between endogenous CHD2 and endogenous KU70 ( Figure 5A ) or GFP-tagged KU70 (Figure S4G) . Notably, this interaction was not affected by PARP inhibition or IR-induced DNA damage ( Figure S4G ). To subsequently test if CHD2 promotes the recruitment of NHEJ factors, we monitored their accumulation at DSBs by live-cell imaging using cells stably expressing GFP-tagged KU70 or GFP-tagged XRCC4. Multiphoton micro-irradiation triggered rapid GFP-KU70 recruitment to DSBs within several seconds (t 1/2 = 5 s; Figure 5B ), whereas GFP-XRCC4 accrual was significantly slower (t 1/2 = 25 s; Figure 5C ). Importantly, the detection of KU70 in laser tracks required much high laser power than that of XRCC4, suggesting that these factors do not accumulate at the same stoichiometric amounts ( Figure S4H ). Importantly, the depletion of CHD2 by two independent siRNAs significantly suppressed both GFP-KU70 ( Figure 5B ) and GFP-XRCC4 ( Figure 5C ; Figure S4I ) recruitment to laser-generated DSBs, whereas the recruitment of GFP-XRCC1 to single-stranded breaks was unaffected ( Figures S4J-S4L ). As expected, GFP-XRCC4 recruitment in these cells was fully dependent on functional KU80 ( Figure 5C ). Moreover, the recruitment of endogenous XRCC4 was also suppressed in CHD2-depleted cells after micro-irradiation (Figures S5A-S5D) and at nuclease-induced DSBs ( Figure 5D ). The levels of localized gH2AX in control or CHD2-depleted cells were similar, showing that CHD2 depletion did not affect DNA damage induction ( Figure 5D ; Figure S5C ). At the single-cell level, we confirmed that cells with decreased GFP-XRCC4 accrual following depletion of CHD2 failed to accumulate endogenous CHD2 in laser tracks, whereas CHD2 did clearly accumulate in control cells ( Figure S5E ). Notably, overexpression of ATPase-dead CHD2 (K515R; Figure S5F ), but not wild-type CHD2, also reduced the recruitment of XRCC4 (Figure 5E ). Together, these findings suggest that the chromatin remodeling activity of CHD2 promotes the efficient assembly of NHEJ complexes at DSBs.
Given that CHD2 recruitment is PARP1 dependent, we next asked whether the CHD2-mediated recruitment of XRCC4 to damaged chromatin relies on PARP1. Micro-irradiation experiments showed that treatment of cells with PARP inhibitor ( Figure 5F ) or siRNAs against PARP1 ( Figure 5G ; Figure S5G ) significantly suppressed GFP-XRCC4 accumulation at laser-generated DSBs. We conclude that PARP1-mediated recruitment of CHD2 is required for the efficient assembly of NHEJ factors.
CHD2 Promotes Chromatin Changes in Response to DNA Damage
The fact that the PARP1-mediated recruitment of CHD2 promotes the assembly of NHEJ complexes raises the question of whether this phenomenon requires CHD2-mediated chromatin remodeling. We first assessed whether CHD2 is capable of mediating large-scale chromatin unfolding by utilizing an in vivo chromatin-remodeling assay ( Figure 6A ). Human U2OS cells harboring a 4-Mbp heterochromatic region containing lactose operator (LacO) repeats were transfected with a plasmid encoding a LacR-tagged single-domain GFP antibody. The resulting fusion protein (aGFP-LacR) efficiently tethered co-expressed GFP-tagged proteins to the LacO array ( Figure 6A ). Tethering of wild-type CHD2-GFP elicited a 2-fold expansion of chromatin at the LacO array compared to tethering GFP only ( Figure 6B ). However, ATPase-dead CHD2 (K515R; Figure S5F ) failed to unfold chromatin, even though it was recruited as efficiently as wild-type CHD2 ( Figure S6A ), whereas a mutant lacking its PAR-binding motif (D1611-1828; Figure 3 ) was proficient in mediating chromatin unfolding ( Figures 6A and 6B) . These findings confirm that CHD2 is an ATP-dependent chromatin remodeler and that its PAR-binding motif (1611-1828) is dispensable for its chromatin-remodeling function.
We next investigated if CHD2 would be required for DNA damage-induced chromatin changes. To this end, we co-expressed NBS1-mCherry together with histone H2A fused to PAGFP-H2A ( Figures 1B and 6C ). Laser micro-irradiation triggered robust recruitment of NBS1 and localized activation of PAGFP-H2A in tracks, which rapidly expanded within the first minutes after irradiation indicative of DNA damage-induced chromatin changes ( Figures 6D and 6F ). Expansion of PAGFP-H2A occurred in both G1 and S/G2 cells ( Figure S6B ) and was not observed in chemically fixed cells (Figures S6C and S6E) , showing that it represents a cell cycle-independent biological phenomenon that is induced by DNA damage. Importantly, when we used laser conditions that efficiently activated PAGFP-H2A and led to recruitment of single-strand break repair factor GFP-XRCC1 but failed to recruit DSB repair factor XRCC4, we did not detect any expansion of H2A tracks ( Figures S6D-S6I ). These findings suggest that laser-induced chromatin changes are linked to the generation of DSBs. Having established conditions to detect DSBinduced chromatin changes, we next examined whether CHD2 is required for these events. Knockdown of CHD2 using two independent siRNAs substantially reduced expansion of PAGFP-H2A ( Figures 6E and 6F ; Figures S6E and S6J) , whereas CHD4 or SNF2H depletion did not affect this process (Figures S6K and S6L) . Similarly, knockdown of CHD2 also impaired unfolding of LacO arrays following DSB induction by the FokI nuclease ( Figure 6G ). Consistent with the PARP1-mediated recruitment of CHD2, we found that the depletion of PARP1 efficiently antagonized chromatin expansion ( Figure 6F ; Figure S6L ). These findings are consistent with a model in which PARP1-mediated recruitment of CHD2 triggers localized chromatin remodeling that promotes the efficient assembly of NHEJ complexes.
PARP1 and CHD2 Link Histone H3.3 to NHEJ To further probe into possible mechanisms that underlie CHD2's ability to promote NHEJ, we turned our attention to histone variant H3.3. Recent studies revealed that CHD2 associates with H3.3 and incorporates this variant at sites of transcription (Harada et al., 2012; Siggens et al., 2015) . Moreover, H3.3 is also incorporated at sites of UV-C-induced DNA damage . To confirm the interaction between these proteins, we performed coIP experiments, which indeed showed a robust interaction between endogenous CHD2 and H3.3 (Figure 7A) . Prompted by these findings, we sought to address whether CHD2 also cooperates with H3.3 in DSB repair. To study this, we generated cells stably expressing low levels of SNAPtagged H3.3, which allows the fluorescent labeling and monitoring of newly synthesized histone H3.3 Figure S7A ). Local micro-irradiation revealed the rapid deposition of H3.3 at sites of DSBs within several minutes after damage induction, which was severely reduced in CHD2depleted cells ( Figures 7C and 7D) . Similarly, overexpression of ATPase-dead CHD2 (K515R; Figure S5F ), but not wild-type CHD2, significantly reduced H3.3 deposition ( Figure 7E ), suggesting that CHD2's chromatin remodeling activity contributes to H3.3 assembly at DSBs. Incorporation of H3.1 could also be detected, albeit much weaker than the H3.3 assembly (Figure S7B) . Importantly, deposition of H3.3 only occurred following micro-irradiation of cells that were pre-sensitized with BrdU, showing that not the UV-A irradiation itself, but rather the generation of laser-induced DSBs caused by BrdU sensitization triggers this response ( Figure S7C ) (Limoli and Ward, 1993) . Considering that CHD2 recruitment is mediated by PARP1, we next addressed if PARP1 is involved in H3.3 deposition. CoIP experiments revealed an interaction between H3.3 and PARP1, which was not enhanced by DNA damage induction ( Figure 7F ). Importantly, treatment of cells with PARP inhibitor or siRNAmediated depletion of PARP1 significantly reduced the de novo incorporation of H3.3 at DSBs (Figures 7G and 7H; . To analyze if H3.3 is required for DSB repair, we transfected siRNAs targeting both H3.3 genes in human cells, which efficiently depleted H3.3 ( Figure 7I ) without affecting cell (legend continued on next page) cycle progression ( Figure S7G ) or the steady-state levels of PARP1 and core NHEJ proteins ( Figure S7H ). Knockdown of H3.3 caused a severe reduction in NHEJ activity as measured by the EJ5-GFP reporter ( Figure 7J ) and the plasmid integration assay ( Figure 7K ). In addition, it also moderately reduced aNHEJ (Figures S7I and S7J) and HR ( Figures S7K and S7L) , the latter of which agrees with a published report (Yang et al., 2013) . Consistent with a defect in DSB repair, we found that loss of H3.3 rendered VH10-SV40 and U2OS cells highly sensitive to IR ( Figure 7L ; Figure S7M ). Notably, knockdown of H3.3 did not affect CHD2 recruitment ( Figures S7N-S7P ), in agreement with the notion that PARP1 and CHD2 act upstream of H3.3. Depletion of H3.3 also did not affect PAGFP-H2A dynamics ( Figures S6K and S7L ), suggesting that CHD2-mediated chromatin expansion precedes H3.3 deposition. Similar to CHD2, coIP experiments revealed that H3.3 interacts with a member of the KU complex (KU80; Figure 7F ). Moreover, just like depletion of PARP1 or CHD2, depletion of H3.3 severely reduced the KU-dependent assembly of XRCC4 in damaged chromatin ( Figures 7M, and7N ). To test if H3.3, similar to CHD2, affects NHEJ-dependent chromosome-end fusions ( Figures 4F-4I ), we simultaneously knocked down both H3.3 genes in mouse TRF2 ts cells and induced telomere uncapping. Strikingly, knockdown of H3.3 by two combinations of shRNAs significantly reduced interchromosomal end fusions ( Figure 7O ). These findings suggest that both CHD2 and H3.3 promote NHEJ-driven chromosome fusion at uncapped telomeres. In summary, our findings suggest that the recruitment of CHD2 by PARP1 triggers the assembly of H3.3 at sites of DNA damage creating an accessible chromatin micro-environment that is amenable for DSB repair by NHEJ ( Figure 7P ).
DISCUSSION
In this study, we established that DSB-containing chromatin undergoes a rapid PARP1-dependent expansion, which coincides with the spreading and efficient recruitment of NHEJ factor XRCC4. The poorly characterized chromatin remodeler CHD2 is the effector of PARP1 in this process and is required for DNA damage-induced chromatin expansion, the DNA damage-induced deposition of histone variant H3.3, and the efficient recruitment and functioning of NHEJ repair complexes.
CHD2 Promotes cNHEJ
Initial studies have revealed that chromatin containing DSBs undergoes rapid ATP-dependent expansion (Kruhlak et al., 2006) . We and others have recently shown that these chromatin changes rely on the activity of PARP enzymes (Khurana et al., 2014; . Our current findings shed light on the underlying molecular mechanism by showing that CHD2 associates with PARP1-generated PAR chains through its C terminus and subsequently promotes DNA damage-induced chromatin expansion. Knockdown of PARP1 or CHD2 significantly reduces, but does not completely abolish chromatin expansion, suggesting that other mechanisms may also contribute to this phenomenon. Although local irradiation of cells using laser micro-irradiation produces different types of DNA lesions, including DSBs and single-stranded breaks, our results suggest that the CHD2-dependent chromatin response requires the presence of DSBs. First, we show that significant chromatin expansion is only observed when using laser conditions that trigger accrual of the DSB repair factor XRCC4. Second, we show that CHD2 promotes the recruitment of the KU complex and XRCC4, both of which respond specifically to DSBs. Third, we find that CHD2 is required for NHEJ-dependent repair of the EJ5-GFP reporter and genomic integration of linearized plasmid DNA. Both of these substrates contain bona fide DSBs generated by endonucleases, and we show that processing of the latter substrate is strictly dependent on canonical NHEJ. Fourth, we find that CHD2 promotes XRCC4 recruitment and chromatin expansion in chromatin surrounding nuclease-induced DSBs. Fifth, and finally, we show in mouse cells that the cNHEJ-dependent fusion of chromosomes containing uncapped telomeres requires the activity of CHD2. Together, these findings argue that the chromatin response mediated by CHD2 is triggered by the presence of DSBs and promotes repair of these lesions by the canonical KU-dependent NHEJ pathway.
PARP1 Contributes to cNHEJ
Our findings reveal that CHD2 is recruited to sites of DNA damage by PARP1 and promotes NHEJ. This raises the question: Is the PARP1-dependent recruitment of CHD2 required for NHEJ?
The current view on NHEJ mechanisms distinguishes a fast KUdependent cNHEJ pathway from a slower PARP1-dependent aNHEJ mechanism (Audebert et al., 2004; Wang et al., 2006) . However, the demonstrated role of PARP1 in aNHEJ does not (D) Quantification of (C). (E) U2OS H3.3-SNAP cells transfected with the indicated GFP constructs were UV-A micro-irradiated, SNAP-labeled, and stained for gH2AX. exclude a role for PARP1 in cNHEJ. Indeed, several studies have implicated PARP1 in cNHEJ, but its contribution is less clear due to conflicting results (reviewed in Pines et al., 2013) . We provide evidence for a role of PARP1 in modulating the efficiency of cNHEJ in human cells. First, we show that both the inhibition and knockdown of PARP1 in human cells significantly reduces the assembly of XRCC4 to laser-induced DSBs. Second, we find that knockdown of PARP1 in human cells reduces the cNHEJ-dependent integration of linearized plasmid DNA. These findings suggest that PARP1 is not essential for cNHEJ, but together with CHD2 it promotes the efficiency of this DSB repair pathway in a chromatin environment.
PARP1 Activation in the Presence of KU Biochemical evidence suggests that KU and PARP1 compete for the binding to broken DNA ends (Cheng et al., 2011; Wang et al., 2006) , raising the question: How does PARP1 stimulate cNHEJ in the presence of functional KU? Interestingly, KU limits but does not prevent PARP1 recruitment to DSBs (Cheng et al., 2011) . Moreover, live-cell imaging revealed that KU dimers exchange rapidly from DNA ends with a t 1/2 of 2 min . This suggests that PARP1 could associate with DSBs recently vacated by KU. Another possibility is that PARP1 associates with DSBs that are not bound by KU and, through CHD2 recruitment, creates a local chromatin environment that promotes the assembly of NHEJ complexes in trans. Either way, our findings support a model in which PARP1 acts upon DSBs in the presence of KU and contributes to DSB repair by cNHEJ. Recent findings have shown that PARP3 also promotes cNHEJ, suggesting that PARP3 can also associate with DSBs in the presence of functional KU (Rulten et al., 2011) . How PARP1 and PARP3 cooperate at DSBs is not clear, but the finding that the combined loss of PARP1 and PARP3 renders mice sensitive to IR beyond the impact of the single disruption of either gene, suggests a functional synergy between these PARP enzymes in the DSBs response (Boehler et al., 2011) .
CHD2 Contains a PAR-Binding Domain
Our findings link PARP1-mediated PAR synthesis to the recruitment of CHD2. Surprisingly, although CHD2 contains a putative PAR-binding domain (Gagné et al., 2008) , we found this domain to be dispensable for DNA damage recruitment. Instead, we identified a C-terminal region located between amino acids 1611 and 1828 to be essential for in vitro PAR binding and the localization of CHD2 at laser-induced DSBs. Interestingly, a heterozygous CHD2 mutant mouse was generated by gene trapping, which expresses a truncated CHD2-b-gal-neomycin fusion protein that contains the first 1198 amino acids of the wild-type protein.
Notably, CHD2 gene-trap mice develop lymphomas, and cells from these mice display signs of defective DSB repair (Nagarajan et al., 2009 ). However, it is unclear whether these phenotypes are caused by a gain-of-function feature of the CHD2 fusion protein or through a loss-of-function feature of CHD2. Using siRNA-and shRNA-mediated knockdown of CHD2 in human and mouse cells, our results provide direct evidence for a role of CHD2 in DSB repair by KU-dependent NHEJ. It is tempting to speculate that the gene-trap allele, which pro-duces a truncated CHD2 protein (CHD2 1-1198 ) lacking the C-terminal PAR-binding region, is not functional due to its inability to associate with PAR chains. This region of CHD2 bears no similarity to other known PAR-binding domains, and it would be interesting to biochemically define how it interacts with PAR chains and whether interactions with PAR stimulate the ATPase activity of CHD2.
A Pathway that Regulates NHEJ in Chromatin How does the PARP1-dependent recruitment of CHD2 promote NHEJ? Our data reveal that, similar to transcription sites (Harada et al., 2012; Siggens et al., 2015) , the deposition of H3.3 at DSBs is regulated by CHD2's chromatin remodeling activity. However, whether CHD2 directly deposits H3.3, as was demonstrated in vitro for the p400 ATPase (Pradhan et al., 2016) , or if it cooperates with known H3.3 chaperones remains to be investigated . Knockdown of H3.3, like knockdown of CHD2, results in a profound defect in DSB repair by NHEJ, suggesting that CHD2 promotes NHEJ, at least in part, through the DNA damage-dependent assembly of H3.3. The deposition of H3.3 may create a chromatin environment that facilitates the assembly of functional NHEJ complexes, and this process may be aided by interactions between H3.3 and the KU complex. Interestingly, somatic mutations in CHD2 and H3.3 genes have been found to drive tumorigenesis (Rodríguez et al., 2015; Yuen and Knoepfler, 2013) , suggesting that the uncovered pathway may contribute to tumor suppression by maintaining genetic stability. In summary, we define a pathway involved in facilitating NHEJ in a chromatin context. Our findings support a model in which PARP1-associated PAR chains attract the chromatin-remodeling activity of CHD2 to deposit histone variant H3.3 and generate an accessible chromatin environment that promotes the efficient assembly of NHEJ complexes at DSBs. In addition to its described role in aNHEJ, PARP1 also contributes to efficient KU-dependent cNHEJ in human cells through its effectors CHD2 and H3.3. The strong link between these factors raises the question whether CHD2 and H3.3 play a role in other genome maintenance pathways that are modulated by PARP1 (Pines et al., 2013) .
EXPERIMENTAL PROCEDURES
Cell Lines, Chemicals, Plasmids, and Transfections Cells (see the Supplemental Information) were cultured in DMEM, supplemented with antibiotics and 10% fetal calf serum. PARP inhibitor (KU-0058948) was used at a concentration of 1-10 mM. The CHD2 cDNA was inserted into pEGFP-N1 (Addgene). All indicated deletion mutants of CHD2 were generated by PCR. Plasmid DNA or siRNAs were transfected using Lipofectamine 2000 or RNAiMAX (Invitrogen). See the Supplemental Information for details on siRNAs, shRNAs, and primers.
Immunoprecipitation for Mass Spectrometry and PAR-Binding
Assay GFP-tagged PARP1 and CHD2 were immunoprecipitated, trypsinized, desalted, and analyzed on a Q-Exactive Orbitrap mass spectrometer (Thermo Scientific, Germany) coupled to an EASY-nanoLC 1000 system (Proxeon, Odense, Denmark). CHD2-GFP fragments were immunoprecipitated, separated by SDS-PAGE, and incubated with radioactive PAR. Radioactivity was detected by a phosphor-imager screen.
Microscopic Analysis
Laser micro-irradiation was performed by UV-A micro-irradiation of BrdUsensitized cells or by multi-photon (MP) irradiation using a titanium-sapphire laser. PAGFP-H2A was photoactivated using the same MP laser and settings as those used to inflict localized DNA damage (see the Supplemental Information for details). Immunostaining was performed as described . Primary antibodies are listed in the Supplemental Information.
H3.3-SNAP Labeling U2OS H3.3-SNAP cells were blocked with SNAP-Cell Block (New England Biolabs), subjected to UV-A micro-irradiation after which newly synthesized histones were labeled with SNAP-cell TMR star (New England Biolabs).
DSB Repair Assays EJ5-GFP, EJ2-GFP, and DR-GFP reporter assays were carried out as described previously . Gel-purified BamHI-EcoRI-linearized pEGFP-C1 plasmid was transfected into siRNA-depleted cells to measure random plasmid integration events (see the Supplemental Information) (Galanty et al., 2009) .
Chromosome Fusion Assays
TRF2 ts MEFs were infected with shRNAs constructs and shifted to the nonpermissive temperature (39 C) for 24 hr to induce telomere uncapping followed by telomere-FISH, as described .
Statistical Analysis
Statistical significance was assessed by a two-tailed, unpaired t test and is indicated as follows: ****p < 0.0001, ***p < 0.001, **p < 0.01, and *p < 0.05. ns, not significant. All error bars represent the SEM. were a gift from Susan Janicki (Janicki et al., 2004) . U2OS 2-6-3 cells stably expressing ER-mCherry-LacR-FokI-DD (Tang et al., 2013) were induced for 5 h by 1 µM Shield-1 (Clontech) and 1 µM 4-OHT (Sigma). HEK293T cells with stably integrated DR-GFP, EJ2-GFP or EJ5-GFP reporters were gifts from Jeremy Stark and Maria Jasin Pierce et al., 1999) . HeLa cells stably expressing KU70-GFP were a gift from Dik van Gent . U2OS cells stably expressing GFP-XRCC1 were a gift from Niels Mailand (Bekker-Jensen et al., 2007) . U2OS cells stably expressing H3.1-SNAP were a gift from Sophie Polo . U2OS cells stably expressing GFP/mCherry-XRCC4, CHD2-GFP or H3.3-SNAP were generated by transfection and selection with puromycin (1 µg/ml) or G418 (400 µg/ml), respectively. U2OS cells stably expressing cell cycle markers mKO-Cdt1, mCherry-geminin or mAG-geminin were generated by lentiviral infection. VH10-hTERT cells stably expressing shRNAs (see list of shRNA sequences) were generated using retroviral infection. Chemicals. PARP inhibitor (KU-0058948) was a gift from Mark O'Connor (Astrazeneca) and used at a concentration of 1-10 μM.
SUPPLEMENTAL INFORMATION
Plasmids. The full-length human CHD2 cDNA (5.5 kb) was amplified by PCR from plasmid pCMV6-XL4-CHD2 (Open Biosystems) and inserted into pEGFP-N1 (Clontech). All indicated deletion mutants or point mutants of CHD2 were generated by PCR and cloning (see list of primers). siRNA-resistant CHD2 was generated by introducing the underlined mutations: GAAGGGAAGGGGCCCGGAAAG.
The CHD2 Fragment 1392-1610 was inserted into GFP-NLS to ensure nuclear localization. The CHD2 1392-1610 and CHD2 1611-1828 cDNA fragments were inserted into pDEST15 in-frame with the GSTcoding sequence. A collection of cDNAs encoding various chromatin remodelers was fused in-frame with either GFP in pEGFP-C1 (Clontech) (CHD4, CHD5, CHD6, CHD7, SNF2H, BRG1) or FLAG in pCDNA3.1 (Invitrogen) (CHD3, INO80). The H3F3B gene was fused in frame with GFP or a SNAP tag (New England Biolabs). pPAGFP-H2A was generated by replacing GFP with PAGFP in the previously described vector pGFP-H2A . The VHH anti-GFP gene (Herce et al., 2013) (a gift of Heinrich Leonardt) was fused in-frame to mCherry-LacR. Lentiviral plamids encoding mKO-Cdt1, mCherry-geminin and mAG-geminin were kind gifts of Atsushi Miyawaki. The XRCC4 cDNA (a gift of Penny Jeggo) was inserted into EGFP-C3-ires-puro. GFP-C3-PARP1 was a gift of Valerie Schreiber (Mortusewicz et al., 2007) . The PARP1 cDNA was inserted into mCherry-LacR-C3. Vectors encoding mCherry-PARG wt or mCherry-PARG E756D were gift of Michael Hendzel . Cell survival assay. VH10-SV40 or U2OS cells were transfected for 48 h with siRNA. Alternatively, VH10-hTERT cells stably expressing shRNAs were used. Cells were trypsinized, seeded at low density and exposed to IR. After 7 days, the cells were washed with 0.9% NaCl and stained with methylene blue. Colonies of more than 20 cells were scored.
Immunoprecipitation for Co-IP. HEK293 cells were transfected with plasmids encoding GFP-PARP1 or CHD2-GFP. For endogenous IPs, the relevant antibody (or corresponding IgG control) was conjugated to Protein A-coupled agarose beads (Millipore 16-157). For immunoprecipitation, cells were lysed in EBC-150 buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 0.5% NP-40, 1 mM EDTA)
supplemented with protease and phosphatase inhibitor cocktails. The lysed cell suspension was sonicated 6 times for 10s on ice and subsequently incubated with 500 U Benzonase for 1 hr under rotation. The NaCl concentration was increased to 300 mM and the suspension was rotated for 20 min. The cleared lysates were subjected to GFP immunoprecipitation with GFP Trap beads (Chromotek) or PARP1/CHD2/KU70 immunoprecipitation with a specific antibody. The beads were then washed 4-6 times with EBC-300 buffer (50 mM Tris, pH 7.5, 300 mM NaCl, 0.5% NP-40, 1 mM EDTA) and boiled in sample buffer. For denaturing IPs, the beads were subsequently washed twice with EBC-1000 buffer (50 mM Tris, pH 7.5, 1 M NaCl, 0.5% NP-40, 1 mM EDTA). Bound proteins were resolved by SDS-PAGE and immunoblotted with the indicated antibodies.
Generation of mass spectrometry samples. For stable isotope labeling by amino acids in cell culture (SILAC) labeling, U2OS cells were cultured for 14 days in media containing 'heavy' (H) and 'light' (L) labeled forms of the amino acids arginine and lysine respectively. SILAC-labeled cells were transiently transfected with CHD2-GFP (H) or empty vector (L) and equal amounts of H-and L-labelled cells were lysed in EBC buffer as described above. CHD2-GFP (H) or empty vector control (L) lysates were subjected to immunoprecipition using GFP Trap beads as described above. The beads were subsequently washed 2 times with EBC-300 buffer and 2 times with 50 mM (NH 4 ) 2 CO 3 followed by overnight digestion using 2.5 µg trypsin at 37°C under constant shaking. Peptides of the H and L precipitates were mixed in a 1:1 ratio and desalted using a Sep-Pak tC18 cartridge by washing with 0.1 % acetic acid. Finally, peptides were eluted with 0.1 % acetic acid/60 % acetonitrile and lyophilized.
Mass spectrometry. Mass spectrometry was performed essentially as previously described (Schimmel et al., 2014) . Samples were analyzed on a Q-Exactive Orbitrap mass spectrometer (Thermo Scientific, Germany) coupled to an EASY-nanoLC 1000 system (Proxeon, Odense, Denmark). Digested peptides were separated using a 13 cm fused silica capillary (ID: 75 µm, OD: 375 µm, Polymicro Technologies, California, US) in-house packed with 1.8 µm C18 beads (Reprospher-DE, Pur, Dr. Maisch, Ammerburch-Entringen, Germany). Peptides were separated by liquid chromatography using a gradient from 2% to 95% acetonitrile with 0.1% formic acid at a flow rate of 200 nl/min for 2 hrs. The mass spectrometer was operated in positive-ion mode at 2.2 kV with the capillary heated to 200°C. Data-dependent acquisition mode was used to automatically switch between full scan MS and MS/MS scans, employing a top 10 method. Full scan MS spectra were obtained with a resolution of 70,000, a target value of 3x10 6 and a scan range from 400 to 2,000 m/z. 
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